DexCom Inc. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.DexCom Inc. (DXCM) shares fell 1.24% to $74.75, marking its third consecutive day of losses and closing 16.93% below its 52-week high. Despite the decline, DXCM outperformed competitors Abbott Laboratories and Insulet Corp., which saw larger drops. The stock traded with lower-than-average volume on a day when major indices like the S&P 500 and Dow Jones rose.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. (DXCM) slid 1.24% to $74.75 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.
This was the stock's third consecutive day of losses.
DexCom Inc. closed 16.93% short of its 52-week high of $89.98, which the company reached on July 30th.
Despite its losses, the stock outperformed some of its competitors Tuesday, as Abbott Laboratories (ABT) fell 1.96% to $99.67 and Insulet Corp. (PODD) fell 2.18% to $163.72.
Trading volume (3.8 M) remained 2.0 million below its 50-day average volume of 5.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-26 1657ET